# FATIMA Trial: EGCG and Vitamin D3 for Prevention of Fibroid Recurrence

> **NCT07647198** · PHASE2 · RECRUITING · sponsor: **Sheikh Shakhbout Medical City** · enrollment: 240 (estimated)

## Conditions studied

- Uterine Fibroids (Leiomyoma)

## Interventions

- **COMBINATION_PRODUCT:** Vitamin D and Green Tea
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07647198
- **Lead sponsor:** Sheikh Shakhbout Medical City
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-22
- **Primary completion:** 2029-08-22
- **Final completion:** 2029-12-22
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2026-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07647198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07647198, "FATIMA Trial: EGCG and Vitamin D3 for Prevention of Fibroid Recurrence". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07647198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*